We assessed the effect of cholecalciferol and calcium supplementation on mRNA expression of cathelicidin (LL-37), Th1 and Th2 cytokines and their transcription factors in the peripheral blood mononuclear cells (PBMCs) in healthy females with vitamin D deficiency (VDD). SUBJECTS/METHODS: Subjects included 131 females with biochemical VDD randomized to receive (a) oral cholecalciferol (60 000 IU/week for 8 weeks followed by 60 000 IU/fortnight (b) calcium (elemental calcium 500 mg twice/day) (c), dual supplementation and (d) placebo for 6 months. The mRNA expression of cathelicidin, Th1 (IFN-g) and Th2 (IL-4 and its antagonist-IL-4d2) cytokines and their transcription factors (T-bet, STAT4, GATA-3, STAT6) were measured in the PBMC by real-time PCR before and after intervention. RESULTS: Cholecalciferol-supplemented groups showed significant rise of mean serum 25(OH)D (30.6 ± 7.51 and 28.6 ± 8.41 ng/ml). The expression of LL-37, IFN-g, IL-4, IL-4d2 and transcription factors were comparable in the four groups at baseline. Despite significant increase in mean serum 25(OH)D in the cholecalciferol-supplemented groups, their mean mRNA transcripts of LL-37, IFN-g, IL-4, transcription factors and their IFN-g/IL-4 and T-bet/GATA-3 ratios were similar to that of calcium and placebo groups. CONCLUSIONS: Six months of cholecalciferol/calcium supplementation in young females with VDD do not lead to significant alteration in mRNA expression of LL-37, Th1/Th2 cytokines and their transcription factors.
INTRODUCTION
Vitamin D deficiency (VDD) and infections such as tuberculosis are common health problems in Asian Indians.
1,2 Functional significance of VDD in Asian Indians is reflected in high prevalence of rickets and osteomalacia and low bone mineral density. 3, 4 In addition to skeletal effects, VDD has been linked with susceptibility to tubercular and bacterial infections of the lungs and autoimmune disorders such as type-1 diabetes and multiple sclerosis. [5] [6] [7] [8] [9] Bergman et al. 10 recently reported a meta-analysis of 11 placebo-controlled randomized clinical trials (RCTs) related to vitamin D supplementation in 5660 patients and observed its protective effect against respiratory tract infection. 10 Vitamin D leads to increased expression of antimicrobial peptide cathelicidin (LL-37) in the epithelial and mononuclear cells under in vitro conditions. [11] [12] [13] Besides, presence of vitamin D receptors in monocytes, dendritic and T cells suggest a role of vitamin D in immune function. 14, 15 Following wide awareness of skeletal and extraskeletal benefits of vitamin D, physicians are frequently supplementing cholecalciferol and calcium to the asymptomatic general population with VDD. However, there is paucity of RCTs on the effect of vitamin D supplementation on the cathelicidin expression and alteration in Th1 and Th2 cytokines.
Most of the earlier studies assessing effect of vitamin D on cathelicidin and change in Th1-and Th2-related cytokines are under in vitro conditions and report downregulation of Th1 or upregulation of Th2 cytokines following addition of 1,25(OH) 2 D to the cell culture. [16] [17] [18] [19] [20] [21] [22] In a RCT involving 9 months of oral cholecalciferol supplementation in 123 patients with congestive heart failure, Schleithoff et al. 23 observed significant increase in serum anti-inflammatory interleukin-10 with no significant rise in serum tumor necrosis factor-a unlike placebo group. There are only limited RCTs assessing effect of cholecalciferol supplementation on Th1-and Th2-related cytokines in healthy subjects with biochemical VDD. [24] [25] [26] Zittermann et al. 24 observed significant improvement in cardiovascular disease risk markers including decrease in proinflammatory serum tumor necrosis factor-a after cholecalciferol supplementation in 200 healthy overweight subjects participating in the weight-reduction program. 26 To the best of our knowledge, there is no RCT assessing change in cathelicidin expression following cholecalciferol supplementation in asymptomatic healthy volunteers with VDD. However, recently, Lehouck et al. 27 observed no significant effect of highdose vitamin D supplementation given for 1 year on the incidence of exacerbations in patients with chronic obstructive pulmonary disease and their plasma cathelicidin levels.
Here, we report the effect of cholecalciferol and calcium supplementation on the mRNA expression of (a) cathelicidin and (b) Th1 and Th2 signatory cytokines (IFN-g, IL-4 and IL-4d2 (IL-4 antagonist) and their transcription factors (T-bet, STAT4, GATA-3, STAT6) in the peripheral blood mononuclear cells (PBMCs) in young females with VDD.
MATERIALS AND METHODS Subjects
Study subjects were a subset of 173 young healthy female volunteers who had participated in our earlier randomized trial during the year 2010-2011 assessing effect of cholecalciferol supplementation on skeletal muscle strength. The details of the trial including randomization, allocation of intervention and its concealment have been published recently. 28 The 131 subjects included for the present report were all those in whom sufficient RNA could be extracted from the PBMC for gene expression analysis at baseline and after 6 months of intervention ( Figure 1) . Briefly, the interventions groups received (a) cholecalciferol 60 000 IU/week for first 8 weeks followed by 60 000 IU/fortnight for 4 months and placebo tablets, (b) calcium carbonate tablet containing 500 mg of elemental calcium given twice daily for 6 months and placebo sachet, (c) both cholecalciferol and calcium in the above-mentioned doses and (d) placebos of lactose tablets and sachets for 6 months. The active arm and placebo for cholecalciferol and calcium carbonate were manufactured by Cadila Pharmaceuticals Ltd, (Ahmedabad, India) and Elder Pharmaceutical Ltd (Mumbai, India), respectively. The blood for measurement of biochemical parameters and gene expression studies was drawn after written informed consent and ethical approval and trial registration (Clinicaltrials.gov.NCT01190683).
RNA isolation for gene expression
Blood for RNA extraction was collected in nuclease-free heparinized tube along with blood drawn for estimation of biochemical parameters, including total serum calcium, inorganic phosphorus, alkaline phosphatase, albumin, 25(OH)D, 1,25(OH) 2 D, intact parathyroid hormone (iPTH). Though biochemical parameters were assessed at baseline, 2 months and 6 months, blood for RNA isolation was drawn only at baseline and 6 months. Briefly, PBMCs were isolated from 5 ml of blood using Ficoll Paque plus (Amersham Biosciences, Piscataway, NJ, USA) and total RNA was extracted using Tri Reagent (Sigma Aldrich, St Louis, MO, USA). The RNA quality and quantity was checked by agarose gel electrophoresis and spectrophotometric (GeneQuant-pro, Amersham Biosciences) analysis respectively. First strand of cDNA was synthesized using 2-mg aliquot of total RNA, 500 mM dNTPs, 5 mM random hexamers, 20 U RNase inhibitor and 200 U M-MuLV reverse transcriptase (RevertAid H Minus, MBI, Fermentas, Vilnius, Lithuania) in a 20-ml reaction at 42 1C for 60 min using GenAmp 9700 thermocycler (Applied Biosystems, Foster City, CA, USA). The cDNA was stored at À 20 1C till the real-time PCR (RT-PCR) assays.
Quantitative RT-PCR analysis
The mRNA expressions of LL-37, Th1 and Th2 cytokines, transcription factors were assessed by RT-PCR. All the RT-PCR assays were put in batches incorporating samples for five genes (cytokines or transcription factors) from six subjects in each PCR plate. A maximum of three RT-PCR assays were run in a day. Gene-specific primers used to amplify glyceraldehyde 3-phosphate dehydrogenase (GAPDH), LL-37, IFN-g, IL-4, IL-4d2, transcription factors and the expected amplicon size are shown in Table 1 . The primers for IFN-g were designed using free software Primer3 (http:// frodo.wi.mit.edu/). The primers for GAPDH, 29 LL-37, 30 IL-4 and IL-4d2, 31 and T-bet, GATA-3 and STAT6 32 and STAT4 were described earlier. 33 The RT-PCR (CFX96, Bio-Rad, Hercules, CA, USA) for all the genes assessed was carried out in separate wells using SYBR-I (Sigma Aldrich) fluorescence signal as described earlier. 29 The conditions for PCR for all genes were: initial denaturation at 94 1C for 3 min, followed by 40 cycles at 94 1C for 30 s, 60 1C for 30 s, 72 1C for 30 s with final extension at 72 1C for 10 min. The cycle threshold for products was measured at 80 1C for IFN-g, IL-4, IL-4d2 and STAT4 and at 86 1C for LL-37, T-bet, GATA-3 and STAT6 based on melting-curve analysis. Reactions were performed in duplicates, and specificity of the amplified products was checked by post-PCR melting-curve analysis and agarose gel electrophoresis. The mRNA expression of various genes was assessed in relation to GAPDH expression. The inter-assay and intra-assay coefficients of variation for cycle threshold for various genes ranged from 0.37% to 2.35% and 0.29% to 2.18%, respectively (Table 1) .
Biochemical estimations
The estimations of serum total calcium, inorganic phosphorus, alkaline phosphatase and serum 25(OH)D, 1,25(OH) 2 D and iPTH were performed by standard methods described earlier. 28 Vitamin D supplementation and cathelicidin M Das et al categorized as deficient, insufficient and sufficient based on values o20.0 ng/ml, 20-32 ng/ml, and 432.0 ng/ml respectively. 1, 34 Statistical analysis
Statistical analysis was performed using the Stata version 12.1. The data were analyzed using per protocol principle and reported as mean ± s.d. The mRNA copy numbers were log transformed for analysis. Comparison of the mRNA expression of various genes at baseline and after intervention in the four study groups was assessed by analysis of variance. The significance of change in various indices used for Th1/Th2 ratio was assessed by Kruskal-Wallis test. Baseline-adjusted comparisons were made using analysis of covariance. Pearson correlation was used to assess correlation between various parameters. P-valueso0.05 were considered significant.
RESULTS
The baseline characteristics of the 131 subjects in the four study groups are shown in (Table 3 ). Figure 2 shows the specific amplification of different genes. The mRNA copy numbers of LL-37, IFN-g, IL-4, IL-4d2, T-bet, STAT4, GATA-3, STAT6 and various indices related to Th1 and Th2 ratios were comparable among the four groups at baseline ( Table 2 ). The pre-intervention mRNA expression levels of the these parameters showed no significant correlation with baseline serum 25(OH)D and 1,25(OH) 2 D values.
Effect of cholecalciferol and calcium supplementation on LL-37, cytokines, transcription factors mRNA expression Differences in the post-intervention mRNA expression of LL-37, Th1 and Th2 cytokines, and transcriptions factors in the four study groups were analyzed in the unadjusted form and also after adjusting for their expression at baseline. The mean mRNA expression of all the genes was comparable in the four groups in both unadjusted and adjusted analysis after 6 months of intervention (Table 3) . Similarly, the delta change (difference between pre and post-intervention) in the expression of the various genes assessed was not significant in both unadjusted and adjusted analysis. Despite significant differences in the serum 25(OH)D in the four groups, the ratios of IFN-g and IL-4 or Vitamin D supplementation and cathelicidin M Das et al transcription factors showed no significant change in Th1 and Th2 predominance with cholecalciferol or calcium supplementation. There was no major change in the mean mRNA expression of the IL-4d2, T-bet, GATA-3 and STAT6. However, the mean mRNA expression of IFN-g and IL-4 increased by two to three folds in all four groups at 6 months in comparison with their baseline values.
DISCUSSION
There has been an increasing interest in the extraskeletal effect of VDD. Intervention studies are being carried out to explore its beneficial in infections such as tuberculosis. 7, 8, 35 Although the mechanisms linking VDD with disorders of bone mineral homeostasis are well investigated, 36 similar information on nonskeletal disorders is limited. Results of the previous in vitro studies have revealed that vitamin D through its nuclear receptor can enhance expression of human-specific antimicrobial peptide LL-37 in immune cells and other tissues. 12, 13 Vitamin D can inhibit Th1 response through vitamin D response elements on the IFN-g gene. 37 It can also indirectly inhibit IFN-g response through inhibition of differentiation of monocytes to antigen-presenting dendritic cells and reduced IL-12 secretion. 38, 39 There are only limited RCTs assessing effect of cholecalciferol supplementation on Th1-and Th2-related cytokines in healthy subjects with biochemical VDD. [24] [25] [26] Following cholecalciferol supplementation, Schleithoff et al. 23 observed significant increase in serum antiinflammatory interleukin-10 in patients with congestive heart failure, and Zittermann et al., 24 observed significant decrease in proinflammatory serum tumor necrosis factor-a after cholecalciferol supplementation in 200 healthy overweight subjects participating in weight-reduction program. 26 On the other hand, vitamin D can also upregulate Th2-specific transcription factor GATA-3. 40 The effect of above-described changes on susceptibility to tubercular infections is not clear. Although increased expression of cathelicidin may be helpful in infections such as tuberculosis, exaggeration of Th2 response would have an opposite effect.
The present study was carried out to explore the extraskeletal effects of vitamin D and calcium on transcription of antimicrobial peptide 'cathelicidin' and IFN-g, IL-4 and Th1-and Th2-related transcription factor genes using doses of cholecalciferol generally used by the physicians to improve vitamin D status. The absence of significant effect of cholecalciferol, calcium or dual supplementation on LL-37 mRNA expression in the PBMC under in vivo conditions is unlike the observations by Bhan et al., 11 reporting significant correlation between plasma LL-37 and serum 25(OH)D. The differences in the results could be because of the differences in the study design and sample size or post-translational effect of vitamin D.
The study also revealed no significant alteration in the mRNA transcripts of IFN-g, IL-4 and IL-4d2 gene with vitamin D, calcium or their dual supplementation. Though the interventions led to major differences in 25(OH)D status, observing no significant differences in their transcriptions factors also supports no alteration in Th1 and Th2 cytokine balance. Further, the observation of no significant correlation between the pre-intervention levels of these cytokines and vitamin D levels also points out to the above view.
There are no similar RCTs or controlled studies assessing the effect of cholecalciferol supplementation on Th1-and Th2-related signatory cytokines and their transcription factors on mRNA expression in apparently healthy normal-weight subjects. However, there are two RCTs with findings similar to that of the present study. 24, 25 Jorde et al. 25 observed no significant differences in the serum IFN-g and IL-4 values in overweight and obese subjects following 1 year of cholecalciferol supplementation (20 000-40 000 IU/week). 24 Similarly, Yusupov et al. 26 observed no significant differences in the serum IFN-g and IL-4 values in the placebo-and cholecalciferol-supplemented (2000 IU/day for 3 months) groups. 25 However, in both these trials, the baseline 25(OH)D values were not in the deficient range with mean values 56 nmol/l (22.4 ng/ml) and 64.3 nmol/l (25.8 ng/ml), respectively. 24, 25 This was unlike the present study, where basal serum 25(OH)D of study groups was in the vitamin D-deficient range. The contrast in pre-and post-supplementation serum 25(OH)D levels observed in the present study would provide effective interpretation in this study.
Interestingly, mRNA expression of IFN-g and IL-4 increased in all four groups at repeat sampling after 6 months in March to April. These variations in expression was unrelated to technical or inter-assay variations because the cycle threshold of housekeeping gene GAPDH showed no significant change before and after intervention. These results are also unlikely to represent seasonal bias in the recruitment of the placebo and active groups because study subjects were recruited within a short span of 2 months and secondly block randomization followed in the study would have ensured seasonal synchronization of the study participants. Moreover, mRNA copy numbers of transcription factors showed no such seasonal change. The trend of seasonal variation in the serum IFN-g observed in the present study is similar to that reported by other investigators in healthy individuals. [41] [42] [43] The results of the present study have some limitations. The cholecalciferol and calcium intervention was carried out in young females for 6 months and therefore cannot be generalized for other age groups, males and for longer duration of supplementation. Further, as the sample size was fixed for the primary objective of assessing the increase in hand-grip strength with vitamin D supplementation, the power of the study to detect significant change in LL-37, IFN-g, IL-4 and IFN-g/IL-4 was only 16%, 9%, 8% and 11%, respectively, with the available number of subjects. With the effect size observed for the above four parameters, a sample size of 500, 436, 622 and 331, respectively, was needed in each group to achieve 80% power. Alternatively, to have 80% power, we need to have 2-2.5 times higher mRNA expression of each parameter after dual supplementation group than the placebo group with the available sample size.
Notwithstanding the above limitations, the present study assessing mRNA expression of the cathelcidin, IFN-g and IL-4 genes coupled with the observations of other investigators on serum levels of IFN-g and IL-4 24, 25 allows us to conclude that 6 months of oral cholecalciferol and calcium supplementation in apparently healthy young females with VDD does not result in significant alteration in the expression of these genes and related transcription factors among health individuals. However, there is a need to extend these studies in subjects with compromised nutrition other than vitamin D, with latent chronic infections and susceptible to autoimmune disorders to have better understanding of the effects of vitamin D supplementation. Vitamin D supplementation and cathelicidin M Das et al
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